News

Astrazeneca’s COVID-19 Vaccine Enters Phase II-III Clinical Trials

Written by Yourway | May 25, 2020

Astrazeneca’s vaccine candidate has advanced to clinical trials with the prospect that it will be available by September. Yourway supports clinical trials to get them advanced to the clinic.